CPDR is a program of the Uniformed Services University of the Health Sciences
and the Henry M. Jackson Foundation for the Advancement of Military Medicine

< Publications Archive

> 2000 Publications

1-10

 

11. Prostate Specific Antigen Levels in Young White and Black Men 20 to 45 Years Old.
Preston DM, Levin LI, Jacobson DJ, Jacobsen SJ, Rubertone M, Holmes E, Murphy GP and Moul JW:,
Urology, 56:5, 2000.

 

12. Treatment of Metastatic Prostate Cancer.
Moul JW:
Brazil J Urology, 26(2): 132-145, 2000.

 

13. Targeted screening for prostate cancer in African-American men.
Moul JW:
Prostate Cancer and Prostatic Diseases, 3:248-255, 2000.

 

14. Screening for Prostate Cancer in African Americans.
Moul JW:
Current Urology Reports 1: 57-64, 2000.

 

15. Prostate Specific Antigen only Progression of Prostate Cancer.
Moul JW:
The J. Urology, 163: 1632-1642, 2000.

 

16. Management of prostate specific antigen increase after definitive treatment of prostate cancer.
Moul JW:
AUA News, October 2000.

 

17. Hormonal Therapy Options for Biochemical Recurrence of Prostate Cancer after Local Therapy.
Moul JW:
Molecular Urology, 4:267-271, 2000.

 

18. The Role of Imaging Studies and Molecular Markers for Selecting Candidates for Radical Prostatectomy.
Moul JW, Kane CJ, and Malkowicz SB:
Urol., Clinics of North America, 2000.

 

19. Gynecomastia in Patients with Prostate Cancer: A Review of Treatment Options.
McLeod DG, Iverson P:
Urology, 213-720, 2000.

 

20. Multicenter Patient Self-Reporting Questionnaire on Impotence, Incontinence and Stricture After Radical Prostatectomy.
Kao TC, Cruess DF, Garner D, Foley J, Seay T, Friedrichs Jr. P, Brantley T, Mooneyhan TR, McLeod DG, and Moul JW:
The Journal of Urology, 163, 858-864, 2000.